%0 Journal Article
%T PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
%A Beate Rau
%A Boris Gabriel
%A Clemens Tempfer
%A Eva-Maria Grischke
%A Giovanni Scambia
%A Michele De Simone
%A Naoual Bakrin
%J Archive of "Pleura and Peritoneum".
%D 2018
%R 10.1515/pp-2018-0114
%X The French Oncologic and Gynecologic HIPEC ¨C FROGHI Grou
%K chemotherapy
%K platin-resistant ovarian cancer (rPROC)
%K Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
%K randomized phase III trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405004/